Trading Signals: SONN Stock Price Prediction and Forecast (Mon. Aug. 24, 2015 - Thu. Apr. 30, 2020)(Sonnet BioTherapeutics Holdings, Inc.)
| SONN latest price $8.7600 (-16.01%) ($7.8400 - $10.1400) on Wed. Apr. 1, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 18.18% (three month average) | RSI | 60 | Latest Price | $8.7600(-16.01%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | SONN declines -2.5% a day on average for past five trading days. | Weekly Trend | SONN declines -1.1% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support SONN advance at 0% a week (0% probability) EWI(64%) EWP(65%) IWC(73%) IVE(63%) FIVG(61%) | Factors Impacting SONN price | SONN will decline at least -9.09% in a week (0% probabilities). VIXM(-35%) UUP(-35%) BND(-28%) VXX(-23%) VCSH(-17%) | | | | | Relative Volatility | | | | Market Trend Strength | -9.09% (StdDev 18.18%) | Hourly BBV | 0 () | Intraday Trend | -13.6% | | | |
|
Resistance Level | $13.31 | 5 Day Moving Average | $12.78(-31.46%) | 10 Day Moving Average | $13.88(-36.89%) | 20 Day Moving Average | $13.31(-34.18%) | To recent high | -67% | To recent low | 0% | Market Cap | $81m | | | | Sonnet BioTherapeutics Holdings, Inc. engages in the development of biologic drugs with enhanced single or bispecific mechanisms. Its technology utilizes a fully human single chain antibody fragment that binds to and hitch-hikes on human serum albumin for transport to target tissues. The company was founded on April 1, 2020 and is headquartered in Princeton, New Jersey. |